Harry M. Jansen Kraemer, Jr. has served on Option Care Health’s Board since 2019. He is the independent Chair of the Board, Chair of the Nominating & Corporate Governance Committee, and a member of the Audit & Finance Committee of the Board.

Mr. Kraemer has served as Clinical Professor of Management and Strategy at the Kellogg School of Management at Northwestern University since 2005. He also served as Executive Partner of Madison Dearborn Partners, a private equity firm, from 2005 to 2025, and previously served as Chairman, President, and Chief Executive Officer of Baxter International Inc., a global, publicly traded manufacturer of healthcare-related products. He is a Certified Public Accountant and currently serves on the board of directors of Leidos Holdings, Inc.

Mr. Kraemer brings to the Board strategic leadership and extensive financial expertise through more than 30 years of executive leadership experience, including his tenure as chief executive officer of a large international public company. He also contributes significant expertise in healthcare, innovation, and capital allocation through his experience in the biotechnology and pharmaceutical sectors and his service on public and private company boards.

Elizabeth D. Bierbower joined Option Care Health’s Board in April 2022. She is an independent director and a member of the Audit & Finance Committee and the Quality, Technology and Compliance Committee of the Board.

Ms. Bierbower most recently served as Chairman and Chief Executive Officer of Friday Health Plans from 2022 to 2023, where she worked with state insurance departments to transition the company into receivership. She previously held multiple leadership roles at Humana, including Segment President, President of Employer Group Segment, Chief Operating Officer of Specialty Benefits, and Vice President of Product Innovation. She currently serves on the board of directors of Progyny, Inc.

Ms. Bierbower brings to the Board strategic leadership, operational experience, and financial expertise through more than 30 years of executive-level experience in the healthcare industry, along with her service on public and private company boards.

Barbara W. Bodem joined Option Care Health’s Board in January 2024. She is an independent director and a member of the Audit & Finance Committee and the Nominating & Corporate Governance Committee of the Board.

Ms. Bodem most recently served as Interim Chief Financial Officer of DENTSPLY Sirona Inc. She previously served as Senior Vice President and Chief Financial Officer of Hill-Rom Holdings, as Senior Vice President of Finance at Mallinckrodt plc, and held senior finance roles at Hospira and Eli Lilly and Company. She currently serves on the boards of BioMarin Pharmaceutical Inc. and Enovis Corporation.

Ms. Bodem is an accomplished financial executive with extensive expertise in finance, accounting, and risk management, as well as significant healthcare industry experience. Her service on multiple public company boards provides additional expertise in governance, audit oversight, and risk management.

Eric K. Brandt joined Option Care Health’s Board in May 2024. He is an independent director and a member of the Compensation Committee and the Quality, Technology and Compliance Committee of the Board.

Mr. Brandt previously served as Chief Financial Officer of Broadcom Inc., a Fortune 500 technology company. He also served as President and Chief Executive Officer of Avanir Pharmaceuticals and as Chief Financial Officer of Allergan Inc., and held earlier roles with The Boston Consulting Group. He currently serves on the boards of Gen Digital Inc., Nutanix, Inc., and Lam Research Corporation.

Mr. Brandt brings significant experience in corporate strategy, finance, and business development, along with technology expertise gained through his leadership of enterprise IT organizations. He also contributes extensive public company governance experience through his service on multiple boards.

Natasha Deckmann, M.D. joined Option Care Health’s Board in April 2022. She is an independent director, Chair of the Quality, Technology and Compliance Committee, and a member of the Nominating & Corporate Governance Committee of the Board.

Dr. Deckmann currently serves as Chief Executive Officer of Tivity Health, a national provider of health and well-being solutions, having previously served as its President and Chief Transformation Officer. She formerly served as Chief Operating Officer and Chief Clinical Officer of SecureSenior Connections, Chief Executive Officer of CarePoint Health System, and held senior leadership roles at Optum and Marsh Inc.

Dr. Deckmann brings to the Board extensive executive leadership and operational expertise, as well as experience in healthcare technology, clinical operations, and business transformation. She also contributes expertise in risk management, governance, and M&A through her leadership roles and board service.

R. Carter Pate has served on Option Care Health’s Board since 2015. He is an independent director and Chair of the Audit & Finance Committee of the Board.

Mr. Pate previously served as Chief Executive Officer of Modivcare Inc. and MV Transportation, Inc., and as Global and U.S. Managing Partner of the Health Care and Government Services Practice at PricewaterhouseCoopers. He currently serves on the board of directors of Purple Innovation, Inc.

Mr. Pate brings extensive executive leadership and financial expertise, deep experience in public company governance, and significant insight into public policy and risk management. He also provides valuable industry perspective through his experience in the home and alternate site infusion sector.

John C. Rademacher is the President and Chief Executive Officer of Option Care Health and has served on the Board since 2019.

Mr. Rademacher has served as President and Chief Executive Officer of Option Care Health since 2018 and previously served as Chief Operating Officer. Prior to joining the Company, he held leadership roles at Cardinal Health, including President of Ambulatory Care and President of Nuclear & Pharmacy Services, and served as Senior Vice President of Cigna.

Mr. Rademacher brings over 25 years of executive leadership experience in the healthcare industry, including expertise in managing nationwide operations and delivering home and alternate site infusion services, along with deep knowledge of the Company’s business and strategy.

Timothy P. Sullivan has served on Option Care Health’s Board since 2015. He is an independent director and a member of the Compensation Committee of the Board.

Mr. Sullivan serves as Vice Chair of Madison Dearborn Partners and previously served as Co-Chief Executive Officer, Co-President, and Co-Founder, Managing Director, and Co-Head of Health Care for the firm.

Mr. Sullivan brings significant executive and human capital management experience, along with deep expertise in private equity investing, value creation, and corporate governance gained through his leadership of a leading global investment firm and his service on numerous boards.

Norman L. Wright joined Option Care Health’s Board in January 2024. He is an independent director, Chair of the Compensation Committee, and a member of the Nominating & Corporate Governance Committee of the Board.

Mr. Wright retired from UnitedHealth Group, where he most recently served as Executive Vice President responsible for health equity strategy, and held additional senior leadership roles at Optum and across customer experience, marketing, and operations. He also previously held executive roles at Citigroup, Accenture, Fidelity Investments, GE, and others. He currently serves on the board of directors of First Solar, Inc.

Mr. Wright brings nearly 40 years of executive experience across multiple industries, including expertise in customer experience, operations, marketing, and strategy. He also contributes significant experience in human capital management, risk management, and sustainability initiatives.